What did we learn about cancer in 2024? How did research advance our understanding of cancer? What new approvals...
As we head into the holiday season, Cancer Research Catalyst has tantalizing teasers in the form of science stocking...
This month, the editors selected studies comparing CAR T therapies for large B-cell lymphoma, assessing a new type of...
This quarter’s 16 approvals include a first-in-class cell therapeutic, a flurry of new options for EGFR-mutated lung cancer, and...
This month, AACR's journals editors highlighted factors that may reduce pancreatic cancer risk, a new humanized mouse model, and...
For World Cancer Research Day, AACR convened a panel of experts to discuss how they are helping to drive...
Researchers are exploring new combinations of therapy, disrupting iron accumulation, and turning tumors hot in attempts to make ovarian...
August’s edition of Editors’ Picks includes biomarkers of immunotherapy response, individualized colorectal screening guidelines, and other exciting research.
The AACR journal editors' picks for July 2024 include a review of the risks from CAR T-cell therapy, advances...
The FDA issued 18 oncology-related approvals in Q2 2024 including two first-in-class drugs and a bispecific T-cell engager for...